Tools for Health and Resilience Implemented After Violence Exposure (Project THRIVE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03703258 |
Recruitment Status :
Recruiting
First Posted : October 11, 2018
Last Update Posted : January 22, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Post Traumatic Stress Disorder Problem Drinking | Behavioral: App-based intervention | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Preventing Risky Drinking and PTSD After Sexual Assault: A Web-Based Intervention |
Actual Study Start Date : | January 13, 2021 |
Estimated Primary Completion Date : | March 1, 2023 |
Estimated Study Completion Date : | September 1, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention
The THRIVE app involves 3 weeks of daily activities. Day 1 involves identification of activities to add to a "self-care activity list" with guidance around selecting activities that increase social contact, reduce alcohol use, and reduce avoidance. They will also complete an active-learning exercise about cognitive distortions and create a "stuck point to-do list" consisting of their cognitive distortions. In subsequent days, participants will be prompted to complete activities from both lists. They will also have access optional activities on topics such as asking for help, preventing isolation, deciding whether to disclose an assault, coping with negative reactions to disclosure, and thinking in helpful ways about social support. They will be prompted to complete brief daily surveys in the app, which will populate a symptom tracker. Participants in will have brief weekly phone contact with a coach to monitor safety and troubleshoot issues with app use.
|
Behavioral: App-based intervention
A app-based cognitive-behavioral intervention to prevent the development of PTSD and high-risk drinking in recently-victimized adults
Other Name: THRIVE app |
No Intervention: Assessment-only control
The assessment-only control condition will involve access to a version of the app that includes daily surveys and a symptom tracker populated by these surveys, but without any of the other exercises included in the experimental version of the app. Participants in the control condition will have brief weekly phone contact with a coach to monitor safety and troubleshoot issues with app use.
|
- Change in problem drinking at 3 weeks [ Time Frame: Baseline, post-intervention (3 weeks after baseline) ]Sum scores on Rutgers Alcohol Problem Index- Short Form (RAPI-S). Range: 0-64; higher scores indicate worse outcome.
- Change in problem drinking at 3 months [ Time Frame: Baseline, 3 month follow-up ]Sum scores on Rutgers Alcohol Problem Index- Short Form (RAPI-S). Range: 0-64; higher scores indicate worse outcome.
- Change in posttraumatic stress symptoms at 3 weeks [ Time Frame: Baseline, post-intervention (3 weeks after baseline) ]Sum scores on PTSD Checklist-5 (PCL-5). Range: 0-80; higher scores indicate worse outcome.
- Change in posttraumatic stress symptoms at 3 months [ Time Frame: Baseline, 3 month follow-up ]Sum scores on PTSD Checklist-5 (PCL-5). Range: 0-80; higher scores indicate worse outcome.
- Anxiety [ Time Frame: Baseline, post-intervention (3 weeks after baseline), 3 month follow-up ]Sum scores on GAD-7. Range: 0-21; higher scores indicate worse outcome.
- Coping self-efficacy [ Time Frame: Baseline, post-intervention (3 weeks after baseline), 3 month follow-up ]Mean scores on the Trauma Coping Self-Efficacy Scale (CSE-T). Range: 1 to 7; higher scores indicate better outcome.
- Depression [ Time Frame: Baseline, post-intervention (3 weeks after baseline), 3 month follow-up ]Sum scores on the PHQ-8. Range: 0-24; higher scores indicate worse outcome.
- Alcohol consumption (quantity) [ Time Frame: Baseline, post-intervention (3 weeks after baseline), 3 month follow-up ]Number of drinks per week reported on the Daily Drinking Questionnaire
- Alcohol consumption (frequency) [ Time Frame: Baseline, post-intervention (3 weeks after baseline), 3 month follow-up ]Number of drinking days per week reported on the Daily Drinking Questionnaire
- Alcohol consumption (hours) [ Time Frame: Baseline, post-intervention (3 weeks after baseline), 3 month follow-up ]Hours spent drinking per week reported on the Daily Drinking Questionnaire

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | Participants who self-identify as female are eligible to participate. |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- informed consent
- self-identification as female
- sexual assault, defined as endorsement of unwanted, attempted or completed sexual contact in the past 10 weeks
- age > 18
- English fluency
- smartphone and internet access at least daily for 3 weeks and at least weekly for 3 months
- consumption of >1 alcoholic drink in the past month
- >1 episode of high-risk drinking in past 6 months, defined as either more than 3 drinks on a given day or more than 7 drinks in a given week
- at least 3 symptom clusters endorsed on the PTSD Checklist.
Exclusion Criteria:
- active suicidality
- psychosis

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03703258
Contact: Emily Dworkin, PhD | 206-221-6932 | edworkin@uw.edu | |
Contact: Christine Lee, PhD | 206-543-6574 | leecm@uw.edu |
United States, Washington | |
University of Washington School of Medicine | Recruiting |
Seattle, Washington, United States, 98105 | |
Contact: Emily R Dworkin, PhD 206-221-6932 edworkin@uw.edu |
Principal Investigator: | Emily Dworkin, PhD | University of Washington |
Responsible Party: | Emily Dworkin, Acting Assistant Professor, School of Medicine: Psychiatry, University of Washington |
ClinicalTrials.gov Identifier: | NCT03703258 |
Other Study ID Numbers: |
STUDY00005025 R00AA026317 ( U.S. NIH Grant/Contract ) |
First Posted: | October 11, 2018 Key Record Dates |
Last Update Posted: | January 22, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Stress Disorders, Traumatic Stress Disorders, Post-Traumatic Trauma and Stressor Related Disorders Mental Disorders |